CLINICAL TRIALS PROFILE FOR ALBUTEROL SULFATE; BUDESONIDE
✉ Email this page to a colleague
All Clinical Trials for albuterol sulfate; budesonide
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT03772223 ↗ | A Study to Compare the Pharmacokinetics of Budesonide and Albuterol Delivered by PT027 Compared With PT007 and PT008 Administered Separately. | Completed | AstraZeneca | Phase 1 | 2019-01-21 | This is a Phase 1 study to compare the pharmacokinetics of budesonide and albuterol delivered by PT027 compared with PT007 and PT008 administered separately. |
| NCT03934333 ↗ | A Study to Compare the Pharmacokinetics of Budesonide Delivered by PT027 Compared With Pulmicort Flexhaler (ELBRUS) | Completed | AstraZeneca | Phase 1 | 2019-05-16 | This study is to compare the systemic exposure of budesonide delivered by the combination inhaler (budesonide/albuterol sulfate pressurized inhalation suspension [BDA metered dose inhaler {BDA MDI}]) with Pulmicort Flexhaler dry-powder inhaler (DPI). |
| NCT05505734 ↗ | A Comparison of PT027 vs PT007 Used as Needed in Participants With Asthma | Not yet recruiting | Parexel | Phase 3 | 2022-08-17 | This is a US study comparing the efficacy and safety of BDA MDI [Budesonide/Albuterol Sulfate (BDA) metered dose inhaler (MDI)] with AS [Albuterol Sulfate] MDI, both are administered as needed for up to 12 months. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for albuterol sulfate; budesonide
Condition Name
Clinical Trial Locations for albuterol sulfate; budesonide
Trials by Country
Clinical Trial Progress for albuterol sulfate; budesonide
Clinical Trial Phase
Clinical Trial Sponsors for albuterol sulfate; budesonide
Sponsor Name
